Modulating the expression of disease genes with RNA-based therapy.
Conventional gene therapy has focused largely on gene replacement in target cells. However, progress from basic research to the clinic has been slow for reasons relating principally to the challenges of heterologous DNA delivery and regulation in vivo. Alternative approaches targeting RNA have the p...
Saved in:
| Main Authors: | Matthew Wood, Haifang Yin, Graham McClorey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-06-01
|
| Series: | PLoS Genetics |
| Online Access: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.0030109&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis
by: Bruna De Felice, et al.
Published: (2025-08-01) -
A synthetic library of RNA control modules for predictable tuning of gene expression in yeast
by: Andrew H Babiskin, et al.
Published: (2011-03-01) -
Switch-like gene expression modulates disease risk
by: Alber Aqil, et al.
Published: (2025-06-01) -
RNA modifications and their role in gene expression
by: I. Made Artika, et al.
Published: (2025-04-01) -
Analyzing the relationship of RNA and DNA methylation with gene expression
by: Shangqian Xie, et al.
Published: (2025-05-01)